Serostim and Weight decreased - a phase IV clinical study of FDA data

Summary:

Weight decreased is reported as a side effect among people who take Serostim (somatropin recombinant), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Norvir, and have Cachexia.

The phase IV clinical study analyzes which people have Weight decreased when taking Serostim. It is created by eHealthMe based on reports of 1,039 people who have side effects when taking Serostim from the FDA, and is updated regularly.

What is Serostim?

Serostim has active ingredients of somatropin recombinant. eHealthMe is studying from 1,047 Serostim users. Check the latest studies of Serostim.

What is Weight decreased?

Weight decreased is found to be associated with 3,392 drugs and 4,747 conditions by eHealthMe. Check the latest studies of Weight decreased.

On Jul, 19, 2026

1,039 people reported to have side effects when taking Serostim.
Among them, 50 people (4.81%) have Weight decreased.

Among these 50 people:

How long have people been on Serostim when they have Weight decreased? *

What is the gender of people who have Weight decreased when taking Serostim? *

female: 12.77 %
male: 87.23 %

What is the age of people who have Weight decreased when taking Serostim? *

What are other drugs people take besides Serostim? *

What are other side effects people have besides Weight decreased? *

Malaise (a feeling of general discomfort or uneasiness): 7 people, 14.00%
Muscle Aches (muscle pain): 7 people, 14.00%
Joint Pain: 7 people, 14.00%
Drug Ineffective: 5 people, 10.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 10.00%
Fatigue (feeling of tiredness): 4 people, 8.00%
Muscle Haemorrhage (bleeding in muscle): 4 people, 8.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 4 people, 8.00%
Buttock Pain: 4 people, 8.00%
Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule): 4 people, 8.00%

What are the existing conditions these people have? *

Cachexia (loss of weight): 20 people, 40.00%
Hiv Infection: 18 people, 36.00%
Testicular Disorder (disease of testes): 2 people, 4.00%
Dermatitis Medicamentosa (an irritation of the scrotum caused by an allergic reaction to a drug): 2 people, 4.00%
Hepatitis C: 2 people, 4.00%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 2 people, 4.00%
Oesophageal Candidiasis (fungal infection of oesophagus): 2 people, 4.00%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 4.00%
Hiv Wasting Syndrome (aids wasting syndrome occurs when you have aids and lose at least 10% of your body weight -- especially muscle): 1 person, 2.00%
Kaposi's Sarcoma (a tumour caused by human herpes virus): 1 person, 2.00%

* Approximation only. Some reports may have incomplete information.

Do you take Serostim and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Serostim:

Serostim (1,047 reports)

Weight decreased treatments and more:

Weight decreased (364,522 reports)

Browse all side effects of Serostim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight decreased:

Weight decreased (3,392 drugs)

Browse all the conditions that are associated with Weight decreased:

Weight decreased (4,747 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Serostim) and Serostim (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.